New hookworm vaccine shows promise in early human trial
NCT ID NCT03172975
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new vaccine to prevent hookworm infection in 39 healthy adults who had never had hookworms before. Participants received different versions of the vaccine and were then exposed to hookworms in a controlled setting to see if the vaccine could prevent infection. The goal was to check safety and how well the vaccine triggers the immune system to fight off the parasite.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOOKWORM INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
George Washington University
Washington D.C., District of Columbia, 20037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.